Can Microscopic Biliary Reconstruction Reduce Biliary Complication Rate in ABO-Incompatible Adult Living Donor Liver Transplantation?

BACKGROUND: With the introduction of rituximab, ABO-incompatible (ABOi) living donor liver transplantation (LDLT) has been considered a feasible and safe procedure to overcome the shortage of organ donors. However, higher biliary complication rates remain an unresolved problem in the ABOi group. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yu-Cheng, Lin, Tsan-Shiun, Lin, Chih-Che, Liu, Yueh-Wei, Wang, Shih-Ho, Wu, Yi-Ju, Li, Wei-Feng, Lin, Yu-Hung, Lin, Ting-Lung, Chan, Yi-Chia, Yeh, Cheng-Hsi, Wang, Chih-Chi, Chen, Chao-Long, Yong, Chee-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406902/
https://www.ncbi.nlm.nih.gov/pubmed/34446690
http://dx.doi.org/10.12659/AOT.931963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406902/
https://www.ncbi.nlm.nih.gov/pubmed/34446690
http://dx.doi.org/10.12659/AOT.931963

Ejemplares similares